Blood Cancer United Announces $7.5 Million Gift From Royalty Pharma to Expand Therapy Acceleration Program

Positive

AI Analysis

Summary

Royalty Pharma announced a $7.5 million donation to Blood Cancer United to expand its therapy acceleration program, with returns to be reinvested to support future therapies.

Importance:2/10

Sentiment:

0.60

philanthropyventure philanthropydrug development fundingblood cancer

Related Companies

$RPRX

Read the original article

Published by PR Newswire Pharma on September 15, 2026 8:30 PM

Read Original